
ShockWave Medical, Inc. – NASDAQ:SWAV
ShockWave Medical stock price monthly change
ShockWave Medical stock price quarterly change
ShockWave Medical stock price yearly change
ShockWave Medical key metrics
Market Cap | 12.56B |
Enterprise value | 8.98B |
P/E | 44.12 |
EV/Sales | 18.34 |
EV/EBITDA | 73.22 |
Price/Sales | 18.54 |
Price/Book | 17.76 |
PEG ratio | 0.01 |
EPS | 4.42 |
Revenue | 787.96M |
EBITDA | 185.11M |
Income | 163.49M |
Revenue Q/Q | 35.84% |
Revenue Y/Y | 41.42% |
Profit margin | 44.1% |
Oper. margin | 25.35% |
Gross margin | 86.73% |
EBIT margin | 25.35% |
EBITDA margin | 23.49% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeShockWave Medical stock price history
ShockWave Medical stock forecast
ShockWave Medical financial statements
Jun 2023 | 180.16M | 28.86M | 16.02% |
---|---|---|---|
Sep 2023 | 186.02M | 34.98M | 18.81% |
Dec 2023 | 202.97M | 44.30M | 21.83% |
Mar 2024 | 218.80M | 55.34M | 25.29% |
Sep 2025 | 285.34M | 60.74M | 21.29% |
---|---|---|---|
Oct 2025 | 287.06M | 62.05M | 21.62% |
Dec 2025 | 312.84M | 68.60M | 21.93% |
Mar 2026 | 299.21M | 60.98M | 20.38% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 786604000 | 169.69M | 21.57% |
---|---|---|---|
Sep 2023 | 1473959000 | 872.71M | 59.21% |
Dec 2023 | 1566563000 | 897.88M | 57.32% |
Mar 2024 | 1643747000 | 891.99M | 54.27% |
Jun 2023 | 39.73M | -83.76M | -95.84M |
---|---|---|---|
Sep 2023 | 50.65M | -305.87M | 612.99M |
Dec 2023 | 71.70M | -242.26M | -164K |
Mar 2024 | 35.84M | -84.45M | 5.01M |
ShockWave Medical alternative data
Aug 2023 | 1,001 |
---|---|
Sep 2023 | 1,001 |
Oct 2023 | 1,001 |
Nov 2023 | 1,001 |
Dec 2023 | 1,001 |
Jan 2024 | 1,001 |
Feb 2024 | 1,001 |
Mar 2024 | 1,468 |
Apr 2024 | 1,468 |
May 2024 | 1,468 |
Jun 2024 | 1,468 |
Jul 2024 | 1,468 |
ShockWave Medical other data
Period | Buy | Sel |
---|---|---|
Apr 2023 | 0 | 10081 |
May 2023 | 0 | 9285 |
Jun 2023 | 0 | 7062 |
Jul 2023 | 0 | 7000 |
Aug 2023 | 0 | 17597 |
Sep 2023 | 0 | 17000 |
Oct 2023 | 0 | 17000 |
Nov 2023 | 0 | 12000 |
Dec 2023 | 0 | 9403 |
Jan 2024 | 0 | 16000 |
Feb 2024 | 0 | 85521 |
Mar 2024 | 0 | 7521 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | PHUNG TRINH officer: VP, Finance | Stock Option | 19,763 | $4.72 | $93,222 | ||
Option | PHUNG TRINH officer: VP, Finance | Common Stock | 16,033 | $6.71 | $107,581 | ||
Option | PHUNG TRINH officer: VP, Finance | Common Stock | 1,339 | $3.42 | $4,574 | ||
Option | PHUNG TRINH officer: VP, Finance | Common Stock | 2,391 | $4.03 | $9,626 | ||
Option | FRANCIS LAURA director | Stock Option | 1,500 | $6.59 | $9,882 | ||
Sale | FRANCIS LAURA director | Common Stock | 1,500 | $300 | $450,000 | ||
Option | FRANCIS LAURA director | Common Stock | 1,500 | $6.59 | $9,882 | ||
Sale | ZACHARIAS ISAAC officer: Presiden.. | Common Stock | 4,000 | $287.67 | $1,150,680 | ||
Option | WATKINS FRANK T director | Stock Option | 2,000 | $3.42 | $6,832 | ||
Option | WATKINS FRANK T director | Common Stock | 2,000 | $3.42 | $6,832 |
Patent |
---|
Application Filling date: 20 Apr 2022 Issue date: 4 Aug 2022 |
Application Filling date: 29 Nov 2021 Issue date: 16 Jun 2022 |
Grant Utility: Shock wave electrodes Filling date: 21 Nov 2019 Issue date: 24 May 2022 |
Application Filling date: 16 Sep 2021 Issue date: 28 Apr 2022 |
Application Filling date: 29 Jun 2021 Issue date: 20 Jan 2022 |
Application Filling date: 15 Apr 2021 Issue date: 4 Nov 2021 |
Application Filling date: 10 Mar 2021 Issue date: 23 Sep 2021 |
Application Filling date: 2 Mar 2021 Issue date: 16 Sep 2021 |
Grant Filling date: 4 Jan 2019 Issue date: 3 Aug 2021 |
Application Filling date: 25 Feb 2021 Issue date: 17 Jun 2021 |
Quarter | Transcript |
---|---|
Q4 2023 15 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 6 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
Q1 2023 8 May 2023 | Q1 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Douglas E. Godshall (1965) Pres, Chief Executive Officer & Director | $972,390 |
Mr. Isaac Zacharias (1975) Chief Commercial Officer | $571,370 |
Mr. Daniel Puckett (1964) Chief Financial Officer & Sec. | $568,340 |
Shockwave Medical: Optimal 2024 Setup For Gains
Buying These 4 Hated Names Devastated By The GLP-1 Hype
Shockwave Medical: Buying The Dip
Shockwave Medical: Interesting Levels Again
The Sell-Off Caused By Wegovy And Mounjaro In Medtech Stocks Offers A Huge Opportunity
Shockwave Medical: Not Worth The Price
August MDA Breakout Stocks Week 32 - 2023: High-Frequency Gainers To Give You An Edge
August MDA Breakout Stocks Week 31 - 2023: High-Frequency Gainers To Give You An Edge
Shockwave Medical: Multiple Growth Levers To Drive Valuation Upside
-
When is ShockWave Medical's next earnings date?
Unfortunately, ShockWave Medical's (SWAV) next earnings date is currently unknown.
-
Does ShockWave Medical pay dividends?
No, ShockWave Medical does not pay dividends.
-
How much money does ShockWave Medical make?
ShockWave Medical has a market capitalization of 12.56B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 49.11% to 730.23M US dollars.
-
What is ShockWave Medical's stock symbol?
ShockWave Medical, Inc. is traded on the NASDAQ under the ticker symbol "SWAV".
-
What is ShockWave Medical's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of ShockWave Medical?
Shares of ShockWave Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are ShockWave Medical's key executives?
ShockWave Medical's management team includes the following people:
- Mr. Douglas E. Godshall Pres, Chief Executive Officer & Director(age: 60, pay: $972,390)
- Mr. Isaac Zacharias Chief Commercial Officer(age: 50, pay: $571,370)
- Mr. Daniel Puckett Chief Financial Officer & Sec.(age: 61, pay: $568,340)
-
How many employees does ShockWave Medical have?
As Jul 2024, ShockWave Medical employs 1,468 workers.
-
When ShockWave Medical went public?
ShockWave Medical, Inc. is publicly traded company for more then 6 years since IPO on 7 Mar 2019.
-
What is ShockWave Medical's official website?
The official website for ShockWave Medical is shockwavemedical.com.
-
Where are ShockWave Medical's headquarters?
ShockWave Medical is headquartered at 5403 Betsy Ross Drive, Santa Clara, CA.
-
How can i contact ShockWave Medical?
ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara, CA and company can be reached via phone at +51 02794262.
ShockWave Medical company profile:

ShockWave Medical, Inc.
shockwavemedical.comNASDAQ
1,468
Medical - Devices
Healthcare
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Santa Clara, CA 95054
CIK: 0001642545
ISIN: US82489T1043
CUSIP: 82489T104